RxDoctor Payments Data

Christopher Huerter, MD

Dermatology · Omaha, NENPI 1801906326

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.7% of the total across 405 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations.

$7,364in general payments, 2019–2025

Across 405 payments — averaging $18.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • AbbVie$1K
  • Lilly USA, LLC$747
  • Sun Pharmaceutical Industries Inc.$652
  • Amgen$566
  • Novartis$419
  • plus $3K from 27 others

What the payments were for

  • Food & beverage$6,68091%
  • Education$6839%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,364 in reported general payments places this provider in the 75th percentile of 68 dermatology providers in Nebraska.

See all dermatology providers in Nebraska

Medicare billing

Part B allowed, 2024
$339,231
Medicare patients
1,098
Services billed
5,213

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira PenAdalimumab13$88,276
Humira(Cf) PenAdalimumab11$71,220
Dupixent PenDupilumab14$53,407
Clobetasol Propionate178$9,405
MethotrexateMethotrexate Sodium116$2,294
Fluticasone Propionate83$1,769
Triamcinolone Acetonide134$989
ValacyclovirValacyclovir Hcl12$886
Minoxidil76$881
Minocycline Hcl32$821
Ketoconazole46$692
Doxycycline Hyclate35$692
Hydroxychloroquine Sulfate13$594
Fluocinonide18$517
Betamethasone Dipropionate12$511

Paid to pharmacies, not to this prescriber.

Other dermatology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →